|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Cancer
:
Blood
:
Non-Hodgkin's Lymphoma
PCBs, Furans May Factor in Risk of Non-Hodgkin Lymphoma
Scientists have found some additional evidence that environmental exposure to polychlorinated biphenyls (PCBs) may be associated with non-Hodgkin lymphoma, according to a study published in the December 1 issue of Cancer Research. By comparing blood levels of PCBs in 100 pairs of healthy volunteers and non-Hodgkin lymphoma patients, Anneclaire De Roos, Ph.D., assistant professor of epidemiology, Fred Hutchinson Cancer Research Center, and colleagues determined that high levels of three specific molecular forms of PCBs are linked to an increased risk of developing cancer that starts in patients� lymph tissue.
Dec 2, 2005 - 8:03:00 PM
Latest Research
:
Cancer
:
Blood
:
Non-Hodgkin's Lymphoma
Tositumomab Brings New Hope for Refractory Non-Hodgkin's Lymphoma
Health Canada has approved a new treatment that could offer hope for those who suffer from what is considered an incurable form of non-Hodgkin's lymphoma (NHL) and who have failed on, or relapsed following, other treatments. Health Canada approved Bexxar(TM) (tositumomab and iodine I 131 tositumomab) therapy for the treatment of patients with CD20 positive relapsed or refractory, low grade, follicular, or transformed non-Hodgkin's lymphoma, including patients with rituximab- refractory NHL.
Sep 10, 2005 - 11:02:00 PM
Latest Research
:
Cancer
:
Blood
:
Non-Hodgkin's Lymphoma
People who drink alcohol have a lower risk of non-Hodgkin's lymphoma (NHL)
People who drink alcohol have a lower risk of non-Hodgkin's lymphoma (NHL) than non-drinkers, researchers at Yale's Department of Epidemiology and Public Health (EPH) write in an article published in Lancet Oncology.
Aug 15, 2005 - 8:26:00 PM
<< prev
next >>
|
